MFS
CPRX

MSI Financial Services’s Catalyst Pharmaceutical CPRX Stock Holding History

MSI Financial Services’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
2,800
– – ﹤0.01% 3330
2016
Q3 		$3K Buy
+2,800
New +$2.52K ﹤0.01% 3321

Other funds holding CPRX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MSI Financial Services's CPRX Position: Q4 2016 in Review

MSI Financial Services held its Catalyst Pharmaceutical (CPRX) position steady in Q4 2016 at 2,800 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3330.

MSI Financial Services first reported a position in CPRX in Q3 2016 and has held it in 2 quarters since. 54 funds tracked by Wall St. Rank hold CPRX as of Q4 2016.

  • MSI Financial Services held 2,800 shares of Catalyst Pharmaceutical worth $3K as of Q4 2016.
  • MSI Financial Services left its Catalyst Pharmaceutical share count unchanged in Q4 2016.
  • Catalyst Pharmaceutical made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3330 holding.
  • MSI Financial Services first reported a position in Catalyst Pharmaceutical in Q3 2016 and has held it in 2 quarters since.
  • 54 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.